Probiotic Bacteria Engineered to Enhance Immune Response Against Pancreatic Cancer

New research indicates that specially engineered probiotic bacteria could strengthen the immune system's ability to target pancreatic cancer. This innovative approach explores leveraging the body's natural defenses to combat a particularly challenging disease. The findings suggest a potential new avenue for developing future cancer therapies.